Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry

PURPOSE: Although adjuvant chemotherapy (CTx) is still recommended for high-risk patients with hormone receptor-positive and human epidermal receptor (HER)-2-negative breast cancer, recent studies found that selected patients with low disease burden may be spared from CTx and receive hormonal treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kangleon-Tan, Hannah Lois, Sim, Jongmin, You, Ji Young, Lee, Eun-Shin, Lee, Haemin, Yang, Sun Moon, Seong, Min-Ki, Park, Eun Hwa, Nam, Seok Jin, Park, Min Ho, Lee, Seokwon, Park, Woo-Chan, Kangleon, Rogelio G., Dy, Crisostomo B., Bae, Soo Youn, Jung, Seung Pil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763778/
https://www.ncbi.nlm.nih.gov/pubmed/36601341
http://dx.doi.org/10.4174/astr.2022.103.6.313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763778/
https://www.ncbi.nlm.nih.gov/pubmed/36601341
http://dx.doi.org/10.4174/astr.2022.103.6.313

Ejemplares similares